# Heidi Kakko

> Heidi Kakko is a Series A investor backing Medical, Health Care and Therapeutics. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Total investments: 5
- Last investment: Jun 2026
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/heidikakko

Heidi Kakko is a Series A investor focused on Medical and Health Care. Heidi Kakko leads the Development Fund´s investment division by preparing the investments and developing the whole market.Heidi has been actively participating in financing and acquiring companies since 1995, she worked on business consultation and finance at the world`s biggest consultation company PricewaterhouseCoopers for more than 10years.Before joining the Development Fund, Heidi worked as an M&A Leader at an international investment company East Partners, focusing on the markets of Ukraine, Russia and Georgia. As an executive manager, Heidi has gained experience working at the biggest BTL agency in the Baltics as well as developing one of the first Estonian training companies into a business school.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.8M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 20% |
| Health Care | 1 | 20% |
| Therapeutics | 1 | 20% |
| Biotechnology | 1 | 20% |
| Manufacturing | 1 | 20% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Funding Round | 2 | 40% |
| Seed | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Norway | 1 | 20% |
| Estonia | 1 | 20% |
| Ireland | 1 | 20% |
| Switzerland | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Nanordica Medical | Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $1.8M | Venture - Series Unknown | Jun 09, 2026 |  |
| Nanordica Medical | Nanordica Medical is an Estonian medical technology company providing the first-line treatment for chronic wounds based on unique patented nanotechnology, a synergy of copper and silver in nanofibers that remove infection and support wound healing.Nanordica Medical launched a veterinary product Ravimus Vet for animal wounds(https://nanordica.com/ravimus.html) and is developing a first-in-class wound dressing for human hard-to-heal wounds like diabetic foot ulcers. They recently completed a clinical trial showing consistently better results in nearly all efficacy parameters observed among the patients treated with the Nanordica wound dressing than those treated with the commercially available silver ions-based active dressing. | $402.7K | Seed | Jan 10, 2023 |  |
| Sensibel | Sensibel commercializes ultra-high-sensitivity MEMS microphones based on an optical MEMS technology. | $16.1M | Series A | Apr 25, 2022 |  |
| Positrigo | Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. | $1.8M | Series A | Jul 30, 2021 |  |
| RemedyBio | RemedyBio is an immunology-focused discovery and development company based in Dublin, Ireland. It has pioneered a new approach to understanding the immune system and the discovery of new therapies. | $9.4M | Venture - Series Unknown | Jul 20, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [2C Ventures](https://shizune.co/investors/profile/2c-ventures) — VC Fund, 1 deal together
- [Amalfi](https://shizune.co/investors/profile/amalfi-0522) — VC Fund, 1 deal together
- [Health Founders](https://shizune.co/investors/profile/health-founders-8d85) — VC Fund, 1 deal together
- [Investinor](https://shizune.co/investors/profile/investinor) — VC Fund, 1 deal together
- [SINTEF Venture AS](https://shizune.co/investors/profile/sintef-tto) — VC Fund, 1 deal together
- [Skagerak Capital](https://shizune.co/investors/profile/skagerak-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Specialist VC](https://shizune.co/investors/profile/united-angels-vc) — VC Fund
- [Superangel](https://shizune.co/investors/profile/superangel) — VC Fund
- [Tera Ventures](https://shizune.co/investors/profile/tera-ventures) — VC Fund

## Featured in investor lists
- [Medical Investors in Estonia](https://shizune.co/investors/medical-investors-estonia)

## FAQ

### What does Heidi Kakko invest in?

Heidi Kakko invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in Norway. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Heidi Kakko's check size?

Heidi Kakko typically joins rounds of $1.8M–$16M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Heidi Kakko participates in.

### When did Heidi Kakko last invest?

The most recent investment recorded for Heidi Kakko closed in Jun 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co